Analyst Ratings for Ovid Therapeutics Inc (OVID)
OVID Rating Summary
OVID Price Target Summary
- Highest: $9.00 (Oppenheimer)
- Lowest: $4.00 (LifeSci Capital)
- Average: $5.63
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$5.63 (+161.6%)
* Over Last 12-Mos
Rating Score: 8.5 / 10
Percentile Rank: 86%
Rating Score: 8.5 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/15/2026 | Wolfe Research | Rudy Li | New Coverage | Outperform (N/A) |
5.00 (N/A) |
2.19 (2.15) |
-1.83% | Details |
| 10/9/2026 | Cantor Fitzgerald | Imogen Mansfield | New Coverage | Overweight (N/A) |
N/A (N/A) |
2.34 (2.15) |
-8.12% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
